Ann: Immutep Investor Update, page-12

howdy bio, I just don't know what the strategy can change to until EFTI proves itself.......We have previously
seen first hand what salesmen type promotion leads to with Martin Rogers in the PRR days and more recently
we have seen Imugene come back to earth with a thud after reaching the heady heights of 60 odd cents without
earnings etc....The market is wary at the moment and jittery with it, Immutep is sitting well and we will be rewarded
if efti's shows it can improve the lives of people who are struggling with treatment that is available now that is not
helping.....Data protocal is in place fo9r a reason, we are about to learn more...